The impact of heart radiation dose in lung SABR.

e20054Background: Lung cancer has poor outcomes, but those patients diagnosed with stage 1 NSCLC have 5-year survival of 60-70%. Stereotactic ablative body radiotherapy (SABR) is routinely consider...